Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1997017446) HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/017446 International Application No.: PCT/US1996/017875
Publication Date: 15.05.1997 International Filing Date: 07.11.1996
Chapter 2 Demand Filed: 06.06.1997
IPC:
A61K 38/00 (2006.01) ,C07K 16/28 (2006.01) ,C07K 16/46 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
28
against receptors, cell surface antigens or cell surface determinants
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
46
Hybrid immunoglobulins
Applicants:
IDEC PHARMACEUTICAL CORPORATION [US/US]; 11011 Torreyana Road San Diego, CA 92121-1104, US
Inventors:
BLACK, Amelia; US
HANNA, Nabil; US
PADLAN, Eduardo, A.; US
NEWMAN, Roland, A.; US
Agent:
TESKIN, Robin, L. ; Burns, Doane, Swecker & Mathis, L.L.P. P.O. Box 1404 Alexandria, VA 22313-1404, US
Priority Data:
08/554,84007.11.1995US
Title (EN) HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
(FR) ANTICORPS HUMANISES DIRIGES CONTRE LA gp39 D'ORIGINE HUMAINE, COMPOSITIONS CONTENANT CES ANTICORPS ET LEUR UTILISATION THERAPEUTIQUE
Abstract:
(EN) The present invention is directed to humanized antibodies which bind human gp39 and their use as therapeutic agents. These humanized antibodies are especially useful for treatment of autoimmune diseases.
(FR) La présente invention concerne des anticorps humanisés se liant à la gp39 d'origine humaine ainsi que leur utilisation comme agents thérapeutiques. Ces anticorps humanisés conviennent particulièrement au traitement des affections auto-immunes.
Designated States: AU, CN, FI, HU, JP, KR, NO, NZ
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
NO19982062EP0862630JP2000500334CN1207127KR1019990067370NZ324500
AU1997011576